Innoviva, Inc. - Director, 10%+ Owner at Armata Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
ARMP on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Innoviva, Inc. since 30 Jan 2025

Holdings reported by Innoviva, Inc. for Armata Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,365,969 $81,829,845 $5.00 31 Mar 2022 Indirect
Common Stock 8,710,800 $43,554,000 $5.00 31 Mar 2022 Direct
Warrants to Purchase Common Stock 8,710,800 $43,554,000 $5.00 31 Mar 2022 Direct Common Stock
Warrants to Purchase Common Stock 2,692,604 $13,463,020 $5.00 31 Mar 2022 Indirect Common Stock
Convertible Debt convertible into Common Stock $30,000,000 10 Jan 2023 Indirect Common Stock

Transactions reported by Innoviva, Inc. for Armata Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.